Table 2.
NPP7 activity in the bile and the results of other clinical chemical analysis in patients in different groups
| Group | NPP7 nmol/h/ml | NPP7 nmol/h/mg | Bilirubin | ALP | GT | n |
|---|---|---|---|---|---|---|
| Gallstone |
311.6 ± 290.1 |
58.21 ± 69.93 |
54.59 ± 63.19 |
2.91 ± 1.60 |
6.69 ± 5.74 |
29 |
| Tumor |
164.9 ± 147.1* |
25.16 ± 14.49* |
161.2 ± 135.3** |
12.2 ± 11.2** |
14.15 ± 9.87* |
13 |
| PSC |
184.4 ± 115.0 |
30.14 ± 26.97 |
56.67 ± 65.68 |
4.39 ± 3.00 |
5.06 ± 5.13 |
10 |
| Others |
312.6 ± 236.1 |
50.95 ± 31.09 |
124.9 ± 197.8 |
4.08 ± 3.52 |
4.75 ± 4.12 |
7 |
| G + O |
311.8 ± 277.3+ |
56.89 ± 63.92+ |
68.25 ± 103.4 |
3.14 ± 2.09 |
6.31 ± 5.47++ |
36 |
| T + PSC | 173.2 ± 131.4* | 27.33 ± 20.45* | 118.5 ± 121.9* | 9.19 ± 9.69** | 10.44 ± 9.31 | 23 |
The results are expressed as Mean ± SD. Statistical significance was determined by non-paired, two tails Mann–Whitney test. *P < 0.05, **P < 0.01 or less compared with gallstone group; + P < 0.05, ++ P < 0.01 or less, compared with tumor group. Significance was also found when gallstone + other benign diseases (G + O) was compared with tumour + PSC (T + PSC) for NPP7 and ALP, either per ml or per mg.